A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Atopic Dermatitis

NCT02583022 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

74

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: PAC-14028 cream 1.0%
DRUG: PAC-14028 cream vehicle
DRUG: Elidel cream 1%

Sponsor

Amorepacific Corporation